Phase I study of PD 0332991, a cyclin-dependent kinase inhibitor, administered in 3-week cycles (Schedule 2 1)
Schwartz, G K, LoRusso, P M, Dickson, M A, Randolph, S S, Shaik, M N, Wilner, K D, Courtney, R, O'Dwyer, P J
Published in British journal of cancer (07.06.2011)
Published in British journal of cancer (07.06.2011)
Get full text
Journal Article
Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations
Myrand, S P, Sekiguchi, K, Man, M Z, Lin, X, Tzeng, R-Y, Teng, C-H, Hee, B, Garrett, M, Kikkawa, H, Lin, C-Y, Eddy, S M, Dostalik, J, Mount, J, Azuma, J, Fujio, Y, Jang, I-J, Shin, S-G, Bleavins, M R, Williams, J A, Paulauskis, J D, Wilner, K D
Published in Clinical pharmacology and therapeutics (01.09.2008)
Published in Clinical pharmacology and therapeutics (01.09.2008)
Get more information
Journal Article
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
Shaw, A.T., Riely, G.J., Bang, Y.-J., Kim, D.-W., Camidge, D.R., Solomon, B.J., Varella-Garcia, M., Iafrate, A.J., Shapiro, G.I., Usari, T., Wang, S.C., Wilner, K.D., Clark, J.W., Ou, S.-H.I.
Published in Annals of oncology (01.07.2019)
Published in Annals of oncology (01.07.2019)
Get full text
Journal Article
Sufficiency of Single‐Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib
Selaru, P, Tang, Y, Huang, B, Polli, A, Wilner, KD, Donnelly, E, Cohen, DP
Published in Clinical and translational science (01.04.2016)
Published in Clinical and translational science (01.04.2016)
Get full text
Journal Article
Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancer
Soria, J.-C., Ho, S.N., Varella-Garcia, M., Iafrate, A.J., Solomon, B.J., Shaw, A.T., Blackhall, F., Mok, T.S., Wu, Y.-L., Pestova, K., Wilner, K.D., Polli, A., Paolini, J., Lanzalone, S., Green, S., Camidge, D.R.
Published in Annals of oncology (01.09.2018)
Published in Annals of oncology (01.09.2018)
Get full text
Journal Article
An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder
Goff, D C, Posever, T, Herz, L, Simmons, J, Kletti, N, Lapierre, K, Wilner, K D, Law, C G, Ko, G N
Published in Journal of clinical psychopharmacology (01.08.1998)
Published in Journal of clinical psychopharmacology (01.08.1998)
Get more information
Journal Article
Efficacy and safety of crizotinib in previously treated patients (Pts) with ALK+ advanced non-small cell lung cancer (NSCLC) aged ≥65 years (y)
Moro-Sibilot, D., Ahn, M.-J., Halmos, B., Kim, D.-W., Riely, G.J., Shaw, A.T., Yang, P.-C., Lanzalone, S., Polli, A., Wilner, K.D., De Castro Carpeño, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Long-term safety of crizotinib in previously treated patients (pts) with ALK-positive advanced/metastatic non-small cell lung cancer (NSCLC)
Crinò, L., Ahn, M.-J., Han, J.-Y., Liu, X., Ou, S.-H.I., Shaw, A.T., Yang, P.-C., Shi, Y.-K., Lanzalone, S., Polli, A., Wilner, K.D., Kim, D.-W.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Single‐ and multiple‐dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers
Wilner, K. D., Tensfeldt, T. G., Baris, B., Smolarek, T. A., Turncliff, R. Z., Colburn, W. A., Hansen, R. A.
Published in British journal of clinical pharmacology (01.01.2000)
Published in British journal of clinical pharmacology (01.01.2000)
Get full text
Journal Article
A Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of CP-101,606 in Patients with a Mild or Moderate Traumatic Brain Injury
MERCHANT, RANDALL E., BULLOCK, M. ROSS, CARMACK, CYNTHIA A., SHAH, AJIT K., WILNER, KEITH D., KO, GRANT, WILLIAMS, STEPHEN A.
Published in Annals of the New York Academy of Sciences (01.01.1999)
Published in Annals of the New York Academy of Sciences (01.01.1999)
Get full text
Journal Article
The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function
Aweeka, F., Jayesekara, D., Horton, M., Swan, S., Lambrecht, L., Wilner, K. D., Sherwood, J., Anziano, R. J., Smolarek, T. A., Turncliff, R. Z.
Published in British journal of clinical pharmacology (01.01.2000)
Published in British journal of clinical pharmacology (01.01.2000)
Get full text
Journal Article
The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid
Wilner, K. D., Hansen, R. A., Folger, C. J., Geoffroy, P.
Published in British journal of clinical pharmacology (01.01.2000)
Published in British journal of clinical pharmacology (01.01.2000)
Get full text
Journal Article
Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers
Wilner, K. D., Demattos, S. B., Anziano, R. J., Apseloff, G., Gerber, N.
Published in British journal of clinical pharmacology (01.01.2000)
Published in British journal of clinical pharmacology (01.01.2000)
Get full text
Journal Article
The effect of timing of a standard meal on the pharmacokinetics and pharmacodynamics of the novel atypical antipsychotic agent ziprasidone
Hamelin, B A, Allard, S, Laplante, L, Miceli, J, Wilner, K D, Tremblay, J, LeBel, M
Published in Pharmacotherapy (01.01.1998)
Published in Pharmacotherapy (01.01.1998)
Get more information
Journal Article
An Open-Label Study of CP-101,606 in Subjects with a Severe Traumatic Head Injury or Spontaneous Intracerebral Hemorrhage
BULLOCK, M. ROSS, MERCHANT, RANDALL E., CARMACK, CYNTHIA A., DOPPENBERG, EGON, SHAH, AJIT K., WILNER, KEITH D., KO, GRANT, WILLIAMS, STEPHEN A.
Published in Annals of the New York Academy of Sciences (01.01.1999)
Published in Annals of the New York Academy of Sciences (01.01.1999)
Get full text
Journal Article
The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function
Everson, G., Lasseter, K. C., Anderson, K. E., Bauer, L. A., Carithens, R. L., Wilner, K. D., Johnson, A., Anziano, R. J., Smolarek, T. A., Turncliff, R. Z.
Published in British journal of clinical pharmacology (01.01.2000)
Published in British journal of clinical pharmacology (01.01.2000)
Get full text
Journal Article
Pharmacokinetics of fluconazole in renal failure
Berl, T, Wilner, K D, Gardner, M, Hansen, R A, Farmer, B, Baris, B A, Henrich, W L
Published in Journal of the American Society of Nephrology (01.08.1995)
Published in Journal of the American Society of Nephrology (01.08.1995)
Get full text
Journal Article